Birmingham, AL · Founded 2020 · Privately Held (backing)
Developer of a digital health platform designed to facilitate an increase in representation and diversity of their genomic research and clinical trials. Acclinate is based in Birmingham, AL and was founded in 2020. Its last reported valuation was $40 million in May 2024. It has raised $15.6 million across 3 recorded rounds; the latest was a $3.5 million seed round in Feb 2026.
Last reported valuation
$40.0M
Oct 2026
Priced at
—
Total raised
$15.6M
Last round
Seed Round
Feb 2026
Cap table — not yet on record
Acclinate's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Acclinate with a free account
·The complete investor list: 24 names
·Watch Acclinate: the Monday email on marks, rounds and moves